Portfolio

Peptomyc announces Research IND Approval for Innovative Window of Opportunity Trial in Collaboration with OHSU Knight Cancer Institute, Portland, Oregon, USA, in PDAC patients December 9, 2024
deepull receives FDA Breakthrough Device Designation for its UllCORE Bloodstream Infection Test December 2, 2024
INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology October 30, 2024
INBRAIN Neuroelectronics Announces World’s First Human Graphene-Based Brain Computer Interface Procedure September 27, 2024
Peptomyc S.L. Expands its Patent Portfolio with a Patent Grant in Hong Kong for its Methods and Composition for the Treatment of Cancer August 27, 2024

Passeig de Gràcia, 20 2n 3a
08007 Barcelona
+34 682 300 704
alta@altals.com